压碎综合症:对医院前提供者和急诊诊医生的审查
Daisuke Usuda1, Shintaro Shimozawa2, Hiroki Takami2
1Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3-1-10, Takanodai, Nerima-City, Tokyo, 177-8521, Japan. d.usuda.qa@juntendo.ac.jp.
Journal of translational medicine
|August 31, 2023
概括
粉碎综合征 (CS) 是一种严重的创伤并发症. 早期识别和积极的医院前治疗对于减少大规模伤亡事件的死亡率至关重要,尽管存在诊断和治疗方面的挑战.
科学领域:
- 紧急医疗 紧急医疗
- 创伤护理 创伤护理
- 灾难医学 灾难医学
背景情况:
- 灾难和事故正在增加,导致大规模的伤亡事件.
- 粉碎综合征 (CS) 的知识已经过时,缺乏基于证据的治疗方法.
- 医院前提供者和急诊医生在CS患者的评估和治疗中至关重要.
研究的目的:
- 提供关于压碎综合征 (CS) 的最新概述.
- 通知医院前提供者和急诊医生关于CS的信息.
- 突出最近在CS诊断和治疗方面的进展.
主要方法:
- 对现有关于粉碎综合征的文献进行叙述性审查.
- 分析历史数据和最近的发展.
- 专注于医院前和急诊临床前景.
主要成果:
- 在地震幸存者中,压碎综合征 (CS) 发生率为2-15%,死亡率高达48%.
- 脊髓炎可能导致心力衰竭,功能障碍,休克,全身炎症和败血症.
- 在脱离之前早期,积极的复苏至关重要,但在大规模灾难中具有挑战性.
结论:
- 优化患者的结果需要提供者对CS有全面的理解.
- 技术和手术的进步已经准备好显著推进CS护理.
- 持续的研究对于解决诊断和治疗CS的挑战至关重要.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Acute Coronary Syndrome V: Nursing Management
16
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16
Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
20
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Cardiopulmonary Resuscitation IV: Pharmacological Management
19
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
19


